CD274 and cancer: Chronic PARP inhibition has been shown to cause sustained DNA damage that promotes several cellular mechanisms, including increased genomic instability, immune pathway activation through generation of neoantigens, and increased programmed cell death ligand 1 (PD-L1) expression on cancer cells, that can promote responsiveness to immune checkpoint inhibitors.36